Whistleblower: Pfizer’s Clinical Trials Were Fraudulent from Head to Toe | Guest: Brook Jackson | 2/23/22
Conservative Review with Daniel Horowitz
00:00
Ventavia Vaccines - I'm So, So Disappointed
Ventavia was mainly paid on a per patient basis. So every single patient that they enrolled into the study was money in their pocket. For fiser, it was being first to market. And i'm certain that that money was, was the driving factor for ventavia. I went to work for ventavia hopeful that, you know, i was going to be part of this company and and helped them... It's just been, it's just been a nightmare since since.
Play episode from 37:08
Transcript
